Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells.

Saved in:
Bibliographic Details
Title: Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells.
Authors: Park JM; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.; School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan.; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan., Su YH; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan., Fan CS; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan., Chen HH; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan., Qiu YK; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.; School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan., Chen LL; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan., Chen HA; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan., Ramasamy TS; Stem Cell Biology Laboratory, Department of Molecular Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia., Chang JS; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.; School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan.; Nutrition Research Center, Taipei Medical University Hospital, Taipei, Taiwan., Huang SY; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.; School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan., Chang WW; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan., Lee AY; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan., Huang TS; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan., Kuo CC; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan. kuocc@nhri.org.tw.; Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan, Taiwan. kuocc@nhri.org.tw., Chiu CF; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan. chiucf@tmu.edu.tw.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan. chiucf@tmu.edu.tw.; Nutrition Research Center, Taipei Medical University Hospital, Taipei, Taiwan. chiucf@tmu.edu.tw.; Taipei Medical University and Affiliated Hospitals Pancreatic Cancer Groups, Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan. chiucf@tmu.edu.tw.
Source: Experimental & molecular medicine [Exp Mol Med] 2025 Mar; Vol. 57 (3), pp. 700-701.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2092-6413
DOI:10.1038/s12276-025-01437-w